Beta-lactamase and Carbapenemase Detection Methods: An Overview of Recent Patents

ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)

Volume 12, 2 Issues, 2017

Download PDF Flyer

Recent Patents on Anti-Infective Drug Discovery

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Dieter Kabelitz
Institute of Immunology
Universitätsklinikum Schleswig-Holstein
Campus Kiel
Arnold-Heller-Straße 3
Kiel, D-24105

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Beta-lactamase and Carbapenemase Detection Methods: An Overview of Recent Patents

Recent Patents on Anti-Infective Drug Discovery, 9(1): 1-5.

Author(s): Meletis Georgios and Bagkeri Maria.

Affiliation: St. Paul General Hospital of Thessaloniki, Greece.


Beta-lactam antibiotics constitute the agents most widely used against bacterial infections worldwide. Hence, the emergence and spread of beta-lactam hydrolyzing enzymes among pathogenic bacteria has proved to be one of the major medical issues especially when these enzymes inactivate carbapenems together with other beta-lactams. The prompt detection of beta-lactamases is important for therapeutic and epidemiological purposes therefore, various appropriate methodologies have been developed throughout the last decades. In the present overview, recent patents related to the detection of beta-lactamases and especially of carbapenemases are discussed.


Beta-lactamases, carbapenemases, patents.

Download Free Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
Issue Number: 1
First Page: 1
Last Page: 5
Page Count: 5
DOI: 10.2174/1574891X09666140608145307

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science